Related Experiment Video
Updated: Jul 24, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
IgA nephropathy in adults-treatment standard
Patrick J Gleeson1,2, Michelle M O'Shaughnessy3, Jonathan Barratt4
1Department of Renal Medicine, Cork University Hospital, Cork, Ireland.
Immunoglobulin A nephropathy (IgAN) is a common kidney disease. Current treatments focus on supportive care and new drugs, with ongoing research into targeted immunomodulation for better outcomes.
Area of Science:
- Nephrology
- Immunology
- Glomerular Diseases
Background:
- Immunoglobulin A nephropathy (IgAN) is the leading cause of primary glomerular disease globally, often leading to kidney failure.
- Pathogenesis involves immune complexes with specific O-glycoforms of IgA1.
- Kidney biopsy with MEST-C scoring is crucial for diagnosis and prognosis.
Conclusions:
- IgAN management is evolving with expanding therapeutic options beyond supportive care.
- Targeted immunomodulation strategies are under investigation for improved efficacy and safety.
- Continued research is vital for refining diagnosis, prognosis, and treatment of IgAN.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Acute Kidney Injury III: Clinical Manifestations

